For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
US demand to rise over 3% annually through 2019
Enzyme demand in the United States is forecast to rise over three percent per year to over $2 billion in 2019. Healthcare reform and efforts to combat rising healthcare costs will lead to changes in the medical and pharmaceutical industries that in turn will result in strong gains in enzymes used in research and biotechnology, in vitro diagnostics, and biocatalysts. In more mature industrial markets, efforts to reduce energy and water use will continue to have a positive impact on enzyme demand. However, declines in US gasoline consumption, along with falling public support for grain-based biofuels and the slow commercialization of new cellulosic biofuel technologies, will restrain growth in the biofuels market.
Biocatalyst uses to benefit from healthcare cost cutting
The increased use of lower cost generic drugs will prompt pharmaceutical companies to improve production processes by using biocatalysts, as well as invest in the development of new biological pharmaceuticals, which will drive strong growth in research and biotechnology enzyme demand. In addition, in response to rising healthcare costs many healthcare providers have begun pursuing a “personalized medicine” approach in which medical care is tailored to the individual, based on their genetic profile, clinical data and personal preferences. Increased diagnostic testing and genome sequencing in support of the personalized medicine approach, along with greater testing due to more insured people undergoing routine medical care, and the generally increased medical care required by an aging population, will further drive enzyme demand.
Key biofuels market to be limited by variety of factors
While the biofuels market was the primary driver of increases in US enzyme demand from 2004 to 2014, growth going forward will be limited, held back by conflicting government policies, changing consumer driving habits and attitudes toward biofuels, and slow commercialization of next-generation biofuel technologies. Government policies that require increasing motor vehicle fleet fuel efficiency will continue to drive declines in gasoline consumption going forward. This will put downward pressure on biofuel consumption and production as falling public support for grain-based biofuels, and vehicle manufacturer reluctance to support higher levels of bio-ethanol in the gasoline supply, limit the government’s ability to enforce the federal renewable fuel standard. Additionally, the slow commercialization of alternative biofuel technologies that are more intensive consumers of enzymes will further limit growth.
Sustainability concerns to boost mature markets
Companies have become increasingly focused on sustainability, including lowering their energy and water use. These concerns will continue to support enzyme demand in otherwise mature industries such as pulp and paper, and textiles and leather. In addition, the continued growth of the renewable chemicals industry, which utilizes enzymes in a number of applications, will be strengthened by manufacturers looking to replace petroleum-based chemicals in their processes. Consumers are also becoming more aware of the environmental impact of household chores. The rising popularity of laundry detergents formulated with more expensive enzymes for cold water washing will support modest growth in cleaning product enzyme demand.
Profiles for over 20 competitors in the US industry, including BASF, DuPont, Novozymes, Roche Holding & Royal DSM
This comprehensive study analyzes the US market for enzymes, which encompasses both specialty and industrial enzymes typically manufactured using fermentative microorganisms, as well as those sourced from plants and animals. Major enzyme market sectors covered in the study include biofuels, food and beverage processing, research and biotechnology, cleaning products, diagnostics, animal feed, and other. Additionally, several smaller markets are also covered, including biocatalysts, dietary supplements, cosmetics and toiletries, textiles and leather, pulp and paper, and others. Specific types of enzymes examined include carbohydrases, proteases, polymerases, nucleases, lipases, and others. Carbohydrases covered include alpha amylases, glucoamylases, cellulases, glucose isomerases, lactases, and pectinases, among others. Cellulases, as covered in this study, include all enzymes acting on cellulosic fiber-type materials, which encompass both cellulases and hemicellulases. Additionally, several smaller markets are also covered, including cosmetics and toiletries, pulp and paper, textiles and leather, and others.
Historical data for 2004, 2009 and 2014 and forecasts for 2019 and 2024 are provided. Unless otherwise indicated, all figures represent demand for enzymes stated in current US dollars. The term “demand” refers to US demand, is used interchangeably with the terms “sales” or “apparent consumption,” and denotes US production, plus imports, minus exports. Data are presented at the manufacturers’ level and may also include captive production and use. Tabular details may not add to totals due to independent rounding and ratios may be rounded for the sake of clarity.